EVH Stock Analysis: Buy, Sell, or Hold?
EVH - Evolent Health, Inc Class A Common Stock
$2.32
0.15 (6.80%)
▲
5d:
+3.0%
30d:
-35.27%
90d:
-43.06%
BUY
MODERATE Confidence
Analysis Updated: Mar 31, 2026 12:00 AM ET
Earnings: May 14, 2026
Smart Money Accumulation
EVH is down 12.9% this week, but smart money is accumulating calls. Top strike: $2.5 2026-06-18 with 53 OI. Call ratio: 100% View Scanner →
Strength: 10.0/10
Get Alerted When EVH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: EVH shows positive signals but monitor for confirmation. Market pricing in 22.6% decline. Moderate conviction.
💡 BUY OPPORTUNITY: EVH shows positive signals but monitor for confirmation. Market pricing in 22.6% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$9.12
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$5.66
59.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: EVH is currently trading at $2.32, which is considered oversold relative to its 30-day fair value range of $2.44 to $3.28. From a valuation perspective, the stock is trading at a discount (Forward PE: 4.9) compared to its historical average (10.6). Remarkably, the market is currently pricing in an annual earnings decline of 22.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, EVH is in a downtrend. Immediate support is located at $2.11, while resistance sits at $2.83. The stock is showing strong short-term momentum, up 6.8% recently.
Market Sentiment: EVH has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.18 (+138.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, EVH is in a downtrend. Immediate support is located at $2.11, while resistance sits at $2.83. The stock is showing strong short-term momentum, up 6.8% recently.
Market Sentiment: EVH has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.18 (+138.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$2.44 -
$3.28
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.8%)
- BULLISH: Trading 138.6% below Wall St target ($5.18)
Fair Price Analysis
30-Day Fair Range
$2.44 -
$3.28
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$2.11
Resistance Level
$2.83
Current Trend
Downtrend
Technical data as of
Mar 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
4.91
Wall Street Target
$5.18
(+138.6%)
Revenue Growth (YoY)
-27.5%
Profit Margin
-28.5%
Valuation Discount vs History
-22.6% cheaper
PE vs Historical
4.9 vs 10.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-22.6%
(market-implied from PE analysis)
1-Year Target
$1.95
(-10%)
2-Year Target
$1.76
(-19%)
3-Year Target
$1.58
(-27%)
3-Yr Target (if PE normalizes)
(PE: 5→11)
$3.41
(+57%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 157.4%)
$33.32
(+1435%)
Base:
(SPY PE: 4.9, Growth: 157.4%)
$7.32
(+238%)
Bear:
(PE: 4.2, Growth: 157.4%)
$6.23
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 4.9 to 10.6
Stabilization Target:
$4.68
(+115.8%)
PE Expansion Potential:
+115.8%
Share & Embed Analysis
Last updated: March 31, 2026 1:56 PM ET
Data refreshes hourly during market hours. Next update: 2:56 PM
Data refreshes hourly during market hours. Next update: 2:56 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EVH showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Brendan B Springstubb
BUY
10000 shares
2025-11-18
Brendan B Springstubb
BUY
10000 shares
2025-11-18
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$271 | 54 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 52 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 58 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$112 | 66 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$28 | 51 HOLD |
Advanced EVH Option Strategies
Professional options setups generated by AI based on today's EVH price and gamma walls.
